DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Requip (Ropinirole) - Confusional State - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Confusional State (25)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Requip (Ropinirole) where reactions include confusional state. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Requip side effects in female

Reported by a consumer/non-health professional from United States on 2012-08-14

Patient: female

Reactions: Confusional State, Agitation, Nightmare, Drug Ineffective, Hyperglycaemia, Rash, Toxicity To Various Agents, Convulsion, Tremor, Weight Increased, Bipolar Disorder, Chest Pain

Drug(s) suspected as cause:
Trileptal

Tizanidine Hydrochloride
    Indication: Migraine

Depakote

Darvocet-N 50

Skelaxin

Prozac

Paxil

Lunesta

Beta Blocking Agents

Topamax

Zonegran

Valium
    Indication: Agitation

Reglan

Abilify

Elavil

Zyprexa

Tegretol

Requip

MAO Inhibitors

Remeron

Buspar

Adderall

Erythromycin

Ritalin

Effexor

Sumatriptan

Wellbutrin

Tofranil

Zoloft

Daytrana

Antidepressants

Steroids NOS

Desyrel

Neurontin

Sinequan

Seroquel

Pamelor

Other drugs received by patient: Aspirin; Vitamin B-Complex, Other Combinations; Ensure; Caltrate +D; ONE A DAY



Possible Requip side effects in female

Reported by a consumer/non-health professional from United States on 2012-07-11

Patient: female

Reactions: Confusional State, Agitation, Nightmare, Drug Ineffective, Hyperglycaemia, Toxicity To Various Agents, Rash, Convulsion, Tremor, Weight Increased, Bipolar Disorder, Chest Pain

Drug(s) suspected as cause:
Tegretol

Requip

Neurontin

Darvocet-N 50

Remeron

Reglan

Depakote

Imitrex

Zonegran

Erythromycin

Ritalin

Sinequan

Elavil

Adderall 5

Wellbutrin

Pamelor

Prozac

Buspar

Lunesta

Trileptal

Topamax

Beta Blocking Agents

Abilify

Valium
    Indication: Agitation

Steroids NOS

Seroquel

MAO Inhibitors

Tofranil

Zoloft

Paxil

Daytrana

Effexor

Skelaxin

Antidepressants

Tizanidine Hydrochloride

Desyrel

Zyprexa

Other drugs received by patient: Vitamin B-Complex, Other Combinations; Caltrate +D; Ensure; ONE A DAY; Aspirin



Possible Requip side effects in male

Reported by a lawyer from France on 2012-06-26

Patient: male

Reactions: Confusional State, Stereotypy, Hallucination, Visual, Exhibitionism

Drug(s) suspected as cause:
Requip



Possible Requip side effects in 47 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-06-26

Patient: 47 year old female

Reactions: Confusional State, Persecutory Delusion, Paranoia, Libido Increased, Delirium

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Modopar (Levodopa)
    Dosage: 125 mg as needed
    Indication: Parkinson's Disease
    Start date: 2012-03-30

Modopar (Levodopa)
    Dosage: 125 mg as needed
    Indication: Parkinson's Disease
    Start date: 2009-01-01
    End date: 2012-03-26

Stalevo 50
    Dosage: 50/12.5/200 mg, 4 times daily:increased to 100/12.5/200 mg 4 times daily:75/12.5/200 mg, 4 df daily
    Administration route: Oral
    Indication: Parkinson's Disease
    Start date: 2009-01-01
    End date: 2012-03-29

Stalevo 50
    Dosage: 50/12.5/200 mg, 4 times daily:increased to 100/12.5/200 mg 4 times daily:75/12.5/200 mg, 4 df daily
    Administration route: Oral
    Indication: Parkinson's Disease
    Start date: 2012-03-30
    End date: 2012-04-01

Stalevo 50
    Dosage: 50/12.5/200 mg, 4 times daily:increased to 100/12.5/200 mg 4 times daily:75/12.5/200 mg, 4 df daily
    Administration route: Oral
    Indication: Parkinson's Disease
    Start date: 2012-04-01

Requip
    Dosage: variable dosage between 16 mg and 20 mg:dose decreased:20 mg: 24 mg daily: 4 mg (2 mg, 2 in 1 d)
    Indication: Parkinson's Disease
    Start date: 2012-02-28

Requip
    Dosage: variable dosage between 16 mg and 20 mg:dose decreased:20 mg: 24 mg daily: 4 mg (2 mg, 2 in 1 d)
    Indication: Parkinson's Disease
    Start date: 2007-06-01
    End date: 2007-01-01

Requip
    Dosage: variable dosage between 16 mg and 20 mg:dose decreased:20 mg: 24 mg daily: 4 mg (2 mg, 2 in 1 d)
    Indication: Parkinson's Disease
    Start date: 2008-05-01

Requip
    Dosage: variable dosage between 16 mg and 20 mg:dose decreased:20 mg: 24 mg daily: 4 mg (2 mg, 2 in 1 d)
    Indication: Parkinson's Disease
    Start date: 2012-02-02

Requip
    Dosage: variable dosage between 16 mg and 20 mg:dose decreased:20 mg: 24 mg daily: 4 mg (2 mg, 2 in 1 d)
    Indication: Parkinson's Disease
    Start date: 2012-03-07
    End date: 2012-03-26

Morphine Sulfate
    Dosage: 1 df; strength: 5 mg
    Administration route: Oral
    Indication: Malaise

Morphine Sulfate
    Dosage: 1 df; strength: 5 mg
    Administration route: Oral
    Indication: Pain

Lyrica
    Dosage: 50 mg
    Indication: Pain
    Start date: 2012-03-07
    End date: 2012-03-26

Other drugs received by patient: Azilect; Clonazepam



Possible Requip side effects in 48 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-06-18

Patient: 48 year old female

Reactions: Anxiety, Confusional State, Persecutory Delusion

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Requip
    Dosage: unk
    Indication: Parkinson's Disease
    Start date: 2007-06-01
    End date: 2007-01-01

Morphine Sulfate
    Indication: Presyncope

Requip
    Dosage: 16 to 20 mg
    Start date: 2008-05-01

Requip
    Dosage: 20 mg, unk
    Start date: 2012-02-28

Stalevo 100
    Dosage: 75 mg, 4x/day
    Administration route: Oral
    Indication: Parkinson's Disease
    Start date: 2009-01-01

Morphine Sulfate
    Dosage: 1 df, 1x/day
    Administration route: Oral
    Indication: Myalgia
    Start date: 2012-03-25
    End date: 2012-03-25

Lyrica
    Dosage: 50 mg, 2x/day
    Administration route: Oral
    Indication: Pain
    Start date: 2012-03-07
    End date: 2012-03-26

Requip
    Dosage: 24 mg, 1x/day
    Administration route: Oral
    Start date: 2012-03-07
    End date: 2012-03-26

Modopar
    Dosage: 1 df, as needed
    Administration route: Oral
    Indication: Parkinson's Disease
    Start date: 2011-01-01
    End date: 2012-03-26

Other drugs received by patient: Clonazepam; Azilect



Possible Requip side effects in female

Reported by a physician from France on 2012-06-15

Patient: female

Reactions: Confusional State, Fatigue, Hallucination

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Requip

Other drugs received by patient: Stalevo 100



Possible Requip side effects in female

Reported by a health professional (non-physician/pharmacist) from France on 2012-06-14

Patient: female

Reactions: Agitation, Confusional State, Persecutory Delusion, Paranoia, Disorientation, Delirium, Anxiety, Libido Increased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Modopar
    Dosage: 125 mg, prn
    Indication: Parkinson's Disease
    Start date: 2009-01-01
    End date: 2012-03-26

Requip
    Dosage: 20 mg, unk
    Start date: 2008-05-01

Modopar
    Dosage: 125 mg, daily
    Start date: 2012-03-30

Requip
    Dosage: 24 mg, unk
    Start date: 2012-03-07
    End date: 2012-03-26

Requip
    Dosage: 2 mg, bid

Morphine Sulfate
    Dosage: 1 df, unk
    Administration route: Oral
    Indication: Pain
    Start date: 2012-03-25

Requip
    Start date: 2012-02-02

Lyrica
    Dosage: 50 mg, unk
    Indication: Pain
    Start date: 2012-03-07
    End date: 2012-03-26

Requip
    Indication: Parkinson's Disease
    Start date: 2007-06-01
    End date: 2007-01-01

Stalevo 100
    Dosage: 200/100/12.5 mg, 4 time daily
    Start date: 2012-04-13

Stalevo 100
    Dosage: 200/75/12.5 mg, 4 time daily
    Administration route: Oral
    Start date: 2012-04-13

Stalevo 100
    Dosage: 200/50/12.5 mg, 4 time daily
    Indication: Parkinson's Disease
    Start date: 2009-01-01
    End date: 2012-03-30

Requip
    Dosage: 20 mg, unk
    Start date: 2012-02-28

Other drugs received by patient: Azilect; Clonazepam



Possible Requip side effects in female

Reported by a physician from France on 2012-06-12

Patient: female

Reactions: Agitation, Confusional State, Anxiety, Persecutory Delusion, Dissociative Fugue, Libido Increased, Delusion

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Modopar
    Dosage: 125mg as required
    Administration route: Oral
    Indication: Parkinson's Disease
    Start date: 2011-01-01
    End date: 2012-03-26

Requip
    Administration route: Oral
    Indication: Parkinson's Disease
    Start date: 2008-05-01
    End date: 2012-03-26

Morphine Sulfate
    Dosage: 5mg single dose
    Administration route: Oral
    Indication: Myalgia
    Start date: 2012-03-25
    End date: 2012-03-25

Stalevo 100
    Dosage: 1tab four times per day
    Administration route: Oral
    Indication: Parkinson's Disease
    Start date: 2009-01-01

Lyrica
    Dosage: 50mg twice per day
    Administration route: Oral
    Indication: Myalgia
    Start date: 2012-03-07

Other drugs received by patient: Azilect; Clonazepam; Lexomil



Possible Requip side effects in 48 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-06-11

Patient: 48 year old female

Reactions: Anxiety, Confusional State, Persecutory Delusion

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Requip
    Dosage: 20 mg, unk
    Start date: 2012-02-28

Requip
    Dosage: 24 mg, 1x/day
    Administration route: Oral
    Start date: 2012-03-07
    End date: 2012-03-26

Requip
    Dosage: unk
    Indication: Parkinson's Disease
    Start date: 2007-06-01
    End date: 2007-01-01

Morphine Sulfate
    Dosage: 1 df, 1x/day
    Administration route: Oral
    Indication: Myalgia
    Start date: 2012-03-25
    End date: 2012-03-25

Morphine Sulfate
    Indication: Presyncope

Lyrica
    Dosage: 50 mg, 2x/day
    Administration route: Oral
    Indication: Pain
    Start date: 2012-03-07
    End date: 2012-03-26

Requip
    Dosage: 16 to 20 mg
    Start date: 2008-05-01

Stalevo 100
    Dosage: 75 mg, 4x/day
    Administration route: Oral
    Indication: Parkinson's Disease
    Start date: 2009-01-01

Modopar
    Dosage: 1 df, as needed
    Administration route: Oral
    Indication: Parkinson's Disease
    Start date: 2009-01-01
    End date: 2012-03-26

Other drugs received by patient: Azilect; Clonazepam



Possible Requip side effects in female

Reported by a consumer/non-health professional from United States on 2012-06-08

Patient: female

Reactions: Agitation, Confusional State, Nightmare, Drug Ineffective, Hyperglycaemia, Rash, Toxicity To Various Agents, Tremor, Convulsion, Weight Increased, Bipolar Disorder, Chest Pain

Drug(s) suspected as cause:
Skelaxin

Elavil

Prozac

Reglan

Tegretol

Depakote

Steroids NOS

Zonegran

MAO Inhibitors

Pamelor

Paxil

Requip

Sinequan

Abilify

Remeron

Tofranil

Buspar

Topamax

Imitrex

Darvocet-N 50

Seroquel

Tizanidine Hydrochloride

Adderall 5

Neurontin

Beta Blocking Agents

Desyrel

Zoloft

Ritalin

Trileptal

Valium
    Indication: Agitation

Lunesta

Daytrana

Erythromycin

Effexor

Antidepressants

Wellbutrin

Zyprexa

Other drugs received by patient: Aspirin; Caltrate +D; ONE A DAY; Vitamin B-Complex, Other Combinations; Ensure



Possible Requip side effects in female

Reported by a physician from France on 2012-06-07

Patient: female

Reactions: Agitation, Confusional State, Anxiety, Dissociative Fugue, Persecutory Delusion, Libido Increased, Delusion

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Requip
    Administration route: Oral
    Indication: Parkinson's Disease
    Start date: 2008-05-01
    End date: 2012-03-26

Lyrica
    Dosage: 50mg twice per day
    Administration route: Oral
    Indication: Myalgia
    Start date: 2012-03-07

Stalevo 100
    Dosage: 1tab four times per day
    Administration route: Oral
    Indication: Parkinson's Disease
    Start date: 2009-01-01

Modopar
    Dosage: 125mg as required
    Administration route: Oral
    Indication: Parkinson's Disease
    End date: 2012-03-26

Morphine Sulfate
    Dosage: 5mg single dose
    Administration route: Oral
    Indication: Myalgia
    Start date: 2012-03-25
    End date: 2012-03-25

Other drugs received by patient: Clonazepam; Lexomil; Azilect



Possible Requip side effects in female

Reported by a health professional (non-physician/pharmacist) from France on 2012-06-05

Patient: female

Reactions: Confusional State, Anxiety, Agitation, Persecutory Delusion, Paranoia, Disorientation, Libido Increased, Delirium

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Requip
    Dosage: 20 mg, unk
    Start date: 2008-05-01

Modopar
    Dosage: 125 mg, daily
    Start date: 2012-03-30

Requip
    Dosage: 20 mg, unk
    Start date: 2012-02-28

Morphine Sulfate
    Dosage: 1 df, unk
    Administration route: Oral
    Indication: Pain
    Start date: 2012-03-25

Stalevo 100
    Dosage: 200/100/12.5 mg, 4 time daily
    Start date: 2012-04-13

Stalevo 100
    Dosage: 200/75/12.5 mg, 4 time daily
    Administration route: Oral
    Start date: 2012-04-13

Requip
    Dosage: 2 mg, bid

Requip
    Start date: 2012-02-02

Modopar
    Dosage: 125 mg, prn
    Indication: Parkinson's Disease
    Start date: 2011-01-01
    End date: 2012-03-26

Lyrica
    Dosage: 50 mg, unk
    Indication: Pain
    Start date: 2012-03-07
    End date: 2012-03-26

Requip
    Dosage: 24 mg, unk
    Start date: 2012-03-07
    End date: 2012-03-26

Stalevo 100
    Dosage: 200/50/12.5 mg, 4 time daily
    Indication: Parkinson's Disease
    Start date: 2009-01-01
    End date: 2012-03-30

Requip
    Dosage: unk
    Indication: Parkinson's Disease
    Start date: 2007-06-01
    End date: 2007-01-01

Other drugs received by patient: Azilect; Clonazepam



Possible Requip side effects in female

Reported by a physician from United States on 2012-05-18

Patient: female

Reactions: Confusional State

Drug(s) suspected as cause:
Skelaxin
    Dosage: unk

Topamax
    Dosage: unk

Effexor
    Dosage: unk

Trileptal
    Dosage: unk

Requip
    Dosage: unk



Possible Requip side effects in 89 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-25

Patient: 89 year old female, weighing 64.4 kg (141.7 pounds)

Reactions: Movement Disorder, Confusional State, Nausea, Personality Disorder, Fall, Syncope, Mental Disorder, Depression, Memory Impairment, Asthenia, Nervousness, Decreased Appetite, Hypersomnia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Requip



Possible Requip side effects in 82 year old male

Reported by a physician from Israel on 2012-03-26

Patient: 82 year old male

Reactions: Confusional State, Memory Impairment, Judgement Impaired

Drug(s) suspected as cause:
Requip



Possible Requip side effects in 89 year old female

Reported by a consumer/non-health professional from United States on 2012-01-25

Patient: 89 year old female

Reactions: Back Pain, Confusional State, Blood Pressure Increased, Vomiting, Nausea, Somnolence, Heart Rate Decreased, Overdose, Malaise, DRY Mouth, Chest Pain, Memory Impairment, Blood Pressure Decreased, Haematoma

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Requip

Other drugs received by patient: Ultram; Vaseretic; Celebrex; Prevacid; Neurontin; Actonel



Possible Requip side effects in 77 year old male

Reported by a pharmacist from Italy on 2011-12-22

Patient: 77 year old male

Reactions: Confusional State, Pleurisy, Hypotension, Drug Administration Error, Urinary Retention, Sopor, Anuria

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Requip
    Dosage: 4 df, unk
    Administration route: Oral
    Start date: 2011-11-06
    End date: 2011-11-06

Lyrica
    Dosage: 1 df 75mg
    Administration route: Oral
    Start date: 2011-11-06
    End date: 2011-11-06

Oxycontin
    Dosage: 1 df, 60mg
    Administration route: Oral
    Start date: 2011-11-06
    End date: 2011-11-06

Other drugs received by patient: Valsartan; Pramipexole Dihydrochloride; Tramadol Hydrochloride and Acetaminophen; Unoprost; Polase; Omeprazole; Madopar; Lasix; Amiodarone HCL; Tolterodine Tartrate



Possible Requip side effects in male

Reported by a health professional (non-physician/pharmacist) from Italy on 2011-12-22

Patient: male

Reactions: Confusional State, Hypotension, Urinary Retention, Sopor, Accidental Exposure

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Oxycontin
    Dosage: 60 mg, single
    Administration route: Oral
    Indication: Accidental Exposure
    Start date: 2011-11-06
    End date: 2011-11-06

Lyrica
    Dosage: 1 df, single
    Administration route: Oral
    Indication: Accidental Exposure
    Start date: 2011-11-06
    End date: 2011-11-06

Requip
    Dosage: 4 df, single
    Administration route: Oral
    Indication: Accidental Exposure
    Start date: 2011-11-06
    End date: 2011-11-06

Other drugs received by patient: Polase; Madopar; Pramipexole Dihydrochloride; Paracetamol W / Tramadol Hydrochloride; Amiodarone HCL; Tolterodine Tartrate; Unoprost / 00685102 /; Valsartan; Omeprazole; Lasix



Possible Requip side effects in male

Reported by a health professional (non-physician/pharmacist) from Italy on 2011-12-02

Patient: male

Reactions: Confusional State, Hypotension, Urinary Retention, Sopor, Accidental Exposure

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Oxycontin
    Dosage: 60 mg, single
    Administration route: Oral
    Indication: Accidental Exposure
    Start date: 2011-11-06
    End date: 2011-11-06

Lyrica
    Dosage: 1 df, single
    Administration route: Oral
    Indication: Accidental Exposure
    Start date: 2011-11-06
    End date: 2011-11-06

Requip
    Dosage: 4 df, single
    Administration route: Oral
    Indication: Accidental Exposure
    Start date: 2011-11-06
    End date: 2011-11-06

Other drugs received by patient: Polase; Pramipexole Dihydrochloride; Paracetamol W / Tramadol Hydrochloride; Madopar; Lasix; Valsartan; Unoprost / 00685102 /; Tolterodine Tartrate; Omeprazole; Amiodarone HCL



Possible Requip side effects in male

Reported by a health professional (non-physician/pharmacist) from Italy on 2011-11-17

Patient: male

Reactions: Confusional State, Hypotension, Urinary Retention, Sopor, Accidental Exposure

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Lyrica
    Dosage: 1 df, single
    Administration route: Oral
    Indication: Accidental Exposure
    Start date: 2011-11-06
    End date: 2011-11-06

Oxycontin
    Dosage: 60 mg, single
    Administration route: Oral
    Indication: Accidental Exposure
    Start date: 2011-11-06
    End date: 2011-11-06

Requip
    Dosage: 4 df, single
    Administration route: Oral
    Indication: Accidental Exposure
    Start date: 2011-11-06
    End date: 2011-11-06

Other drugs received by patient: Polase; Madopar; Pramipexole Dihydrochloride; Lasix; Unoprost / 00685102 /; Tolterodine Tartrate; Paracetamol W / Tramadol Hydrochloride; Omeprazole; Valsartan; Amiodarone HCL



Possible Requip side effects in male

Reported by a physician from Italy on 2011-11-17

Patient: male

Reactions: Confusional State, Hypotension, Drug Administration Error, Urinary Retention, Sopor

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Lyrica
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-11-06
    End date: 2011-11-06

Oxycontin
    Dosage: 60mg per day
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-11-06
    End date: 2011-11-06

Requip
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-11-06
    End date: 2011-11-06

Other drugs received by patient: Pramipexole Dihydrochloride; Amiodarone HCL; Madopar; Unknown Drug; Polase; Omeprazole; Lasix; Unoprost; Tolterodine Tartrate; Unknown Drug



Possible Requip side effects in 69 year old male

Reported by a consumer/non-health professional from Germany on 2011-11-04

Patient: 69 year old male

Reactions: Confusional State, Fatigue, Pleurothotonus, Pain, Hallucination

Drug(s) suspected as cause:
Azilect

Requip
    Dosage: 16mg per day
    Administration route: Oral
    Indication: Parkinson's Disease

Metoclopramide Hydrochloride

Amantadine HCL



Possible Requip side effects in 55 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2011-11-03

Patient: 55 year old male, weighing 106.4 kg (234.1 pounds)

Reactions: Confusional State, Hallucination, Auditory, Abnormal Behaviour, Disorientation, Aggression, Incoherent, Hepatic Encephalopathy, Asterixis, Hallucination, Visual, Insomnia, Acute Psychosis, Lethargy

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Requip
    Dosage: 1.5mg per day
    Administration route: Oral
    Indication: Restless Legs Syndrome
    End date: 2011-10-08

Blinded Study Medication

Other drugs received by patient: Furosemide; Lactulose; Aripiprazole; Propranolol; Combivent; Citalopram Hydrobromide; Calcium Carbonate; Cipro; Hydroxine; Rifaximin; Potassium Chloride; Lithium Carbonate; Amitriptyline HCL; Zinc Sulfate; Levothyroxine Sodium



Possible Requip side effects in male

Reported by a consumer/non-health professional from France on 2011-11-03

Patient: male

Reactions: Confusional State, Stereotypy, Hallucination, Visual, Exhibitionism

Drug(s) suspected as cause:
Requip



Possible Requip side effects in 86 year old male

Reported by a consumer/non-health professional from United States on 2011-10-07

Patient: 86 year old male, weighing 61.2 kg (134.7 pounds)

Reactions: Confusional State, Malaise, Wrong Drug Administered, Dehydration, Asthenia, Drug Dispensing Error, Tremor

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Requip

Other drugs received by patient: Risperidone; Sinemet

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012